ATX-081 is primarily utilized in the field of oncology as a potential therapeutic agent. It functions as a selective inhibitor targeting specific pathways involved in cancer cell proliferation and survival. Its application is particularly significant in research focused on developing treatments for various types of cancers, where it is studied for its ability to inhibit tumor growth and enhance the efficacy of other cancer therapies. Additionally, ATX-081 is being explored for its potential to overcome drug resistance in certain cancer types, making it a valuable compound in the ongoing search for more effective cancer treatments.